Matthieu Chodorge
AstraZeneca (United Kingdom) · 16 works · 761 citations · h-index 10
Top works
- Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody
- Rational Strategies for Directed Evolution of Biocatalysts –Application to Candida antarctica lipase B (CALB)
- Abstract LB-158: MEDI4736: Delivering effective blockade of immunosupression to enhance tumour rejection: Monoclonal antibody discovery and preclinical development
- A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency
- MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential
- Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism
- Rate of Asparagine Deamidation in a Monoclonal Antibody Correlating with Hydrogen Exchange Rate at Adjacent Downstream Residues
- In vitro DNA recombination by L-Shuffling during ribosome display affinity maturation of an anti-Fas antibody increases the population of improved variants
- In vitro evolution of antibody affinity via insertional scanning mutagenesis of an entire antibody variable region
- Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment
- A Shorter Route to Antibody Binders via Quantitative in vitro Bead-Display Screening and Consensus Analysis
- Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facility
- An iteratively optimised process for improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facility
- A Shorter Route to Antibody Binders $\textit{via}$ Quantitative $\textit{in vitro}$ Bead-Display Screening and Consensus Analysis